lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
Ran Wang,1,* Xinxing Lu,2,* Riyue Yu1 1Department of Stomatology, Beijing Shijitan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China*These...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-05-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/lncrna-malat1-promotes-emt-process-and-cisplatin-resistance-of-oral-sq-peer-reviewed-article-OTT |